NCT05200598Completed
Cardiovascular Risk Predictors in Patients With Psoriasis
Source: ClinicalTrials.gov · Last updated 8 Oct 2024
Brief summary (registry, in English)
The investigators are planning to find the right modification of traditionally used risk scores (PASI, DLQI) in patients with psoriasis of different severity to guide the treatment that could potentially extend life, improve cardiovascular outcomes and quality of life in patients with psoriasis and cardiovascular risk factors in a prospective observational study. The traditionally excluded groups of older patients with diabetes mellitus, decreased kidney function and those with potentially worse prognosis are going to be included in the study. As it's known, the number of those patients is on the rise each year and require a close attention of multidisciplinary teams.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 200 (actual)
- First submitted
- 1 Jan 2022
- Start date
- 1 Oct 2021
- Primary completion date
- 1 Sept 2023
- Lead sponsor
- I.M. Sechenov First Moscow State Medical University
- Diseases
- Psoriasis
- NCT number
- NCT05200598
What you commit to
- Study type: Observational
- Participants enrolled: 200
- From 1 Oct 2021 to the primary completion date, 1 Sept 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Life-threatening, independently influencing prognosis and disabling diseases,
- Mental disorders that do not allow to give informed consent or answer questions adequately
Age
- Age under 18
Other
- Pregnancy, lactation
- Very high cardiovascular risk
- Refuse of the patient to participate in the study
Who the study is looking for
- Age over 18 years
- Written informed consent of the patient to participate in the study
Age in the registry: 18 years to 90 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Clinical Hospital #2 Coordinator of this site? Confirm its status | Moscow | Russia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.